Video
Dr. Ranjith Ramasamy discusses research evaluating COVID-19 and erectile dysfunction
Author(s):
“I think doctors should be aware that if men do complain of erectile dysfunction after [having] COVID-19 that it could be because of underlying endothelial dysfunction and underlying vasculature issues,” Ramasamy says.
Video Player is loading.
In this interview, Ranjith Ramasamy, MD, discusses the recent World Journal of Men’s Health study, “COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis,” for which he served as senior author. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Related Videos
An expert discusses patient counseling in wake of FDA’s labeling changes for testosterone
FDA testosterone labeling changes: How will they affect prescribing?
Landon Trost, MD, on the impact of the FDA labeling changes for testosterone products
How urologists can discuss testosterone labeling changes with patients
John P. Mulhall, MD, shares his reaction to the FDA’s testosterone labeling changes
An expert shares their approach to testosterone therapy in men with hypogonadism
Helen L. Bernie, DO, MPH, on the FDA’s labeling changes for testosterone products
Experts consider efficacy of fertility restoration vs sperm cryopreservation
Dayna R. Smerina and Amy M. Pearlman, MD, discuss their research in sexual medicine
Matthew Mutter, MD, shares data on Separo vessel sealing system for vasectomy
Related Content
